“…Most research has focused on: (1) the hypothalamic-pituitary-adrenal (HPA) axis, (2) the ascending brainstem locus coeruleus noradrenergic system, and (3) the limbic amygdalar frontal pathway mediating fear processing. Among the over 25 PTSD candidate genes currently reported (Amstadter et al, 2009(Amstadter et al, , 2011Binder et al, 2008;Boscarino et al, 2011;Cao et al, 2013;Comings et al, 1996;Dragan and Oniszczenko, 2009;Gillespie et al, 2013;Goenjian et al, 2012;Grabe et al, 2009;Guffanti et al, 2013;Hauer et al, 2011;Kolassa et al, 2010;Logue et al, 2013a,b;Lyons et al, 2013;Mellman et al, 2009;Nelson et al, 2009;Ressler et al, 2011;Segman et al, 2002;Solovieff et al, 2014;Voisey et al, 2010;Wilker et al, 2013;Xie et al, 2013), promising findings include associations of PTSD symptoms with the serotonin transporter gene (SERT, SLC6A4) (Xie et al, 2009), which is linked to depression and anxiety disorders, as well as differential acquisition of conditioned fear and increased amygdala excitability in humans. In addition, FKBP5, a co-chaperone of the glucocorticoid receptor involved in the HPA axis, has a significant interaction with severity of child abuse in the prediction of adult PTSD symptoms, indicating a gene by environment (GxE) interaction (Binder et al, 2008).…”